Nvidia Stock Price Prediction: 95% of Analysts Stay Bullish

NVIDIA’s 24/7 Wall St. price target is $245.91, implying 27.73% upside from the June 26 close of $192.53, with a BUY rating and 90% confidence. The article highlights strong fundamentals, including Q1 FY2027 revenue of $81.615 billion (+85.23% YoY), non-GAAP EPS of $1.87, and Q2 guidance of $91 billion, while noting continued AI demand and $119 billion in supply commitments. Risks center on China export controls, margin pressure during the Blackwell/Vera Rubin transition, and insider selling, but even the bear case remains positive at $212.99.

Analysis

The market is treating NVDA like a single-stock expression of the AI capex cycle, but the more important second-order effect is that it is now becoming the financing layer for the ecosystem. If hyperscalers and model builders keep committing at this pace, NVDA’s delivery schedule and gross margin stability matter as much as raw demand because a small slip in ramp timing can ripple through META, MSFT, ORCL, and even TSM utilization expectations. That makes the current pullback less about weakening fundamentals and more about whether the market is willing to pay up before the next margin-inflection proof point.

The more interesting asymmetry is in the supply chain. TSM is the quiet bottleneck: if Blackwell/Vera Rubin volumes ramp faster than expected, wafer starts, advanced packaging, and HBM allocation become the real constraint, which means suppliers can outperform even if NVDA consolidates. Conversely, RDDT’s weak sentiment signal is a reminder that retail AI enthusiasm is vulnerable to “valuation fatigue”; if NVDA can’t reclaim momentum, the overowned AI basket could see de-grossing into month-end and over the next 4-8 weeks.

The consensus likely underestimates how much of the current bull case is already baked into the industrial complex around NVDA. A sustained upside surprise probably benefits the whole AI adjacency trade, but a guide miss or margin wobble would hit the highest-beta beneficiaries first: TSM on throughput concerns, ORCL/MSFT on capex digestion, and META on multiple compression as investors question the payback on incremental AI spend. China remains the key tail risk because it is not just a revenue issue; tighter export rules would force the street to revisit the entire demand-duration assumption, which is what supports the 2027-2030 trajectory more than the next quarter does.

Key Decisions for Investors

• Buy NVDA on further 3-5% weakness over the next 1-2 weeks; use a tight downside stop below the recent monthly low because the setup is a catalyst-driven continuation trade, not a long-duration value call.
• Relative value: long NVDA / short RDDT for 1-3 months to express that institutional AI demand is stronger than retail AI enthusiasm; reward is de-grossing on the short leg if sentiment stays fragile.
• Pair trade: long NVDA / short TSM into the next earnings window if you believe NVDA can preserve pricing power while TSM absorbs execution risk; this works best if guidance stays strong but supply-chain commentary gets cautious.
• For event risk, buy NVDA call spreads 6-9 months out, struck around current spot to the $240-$260 area, to express upside without paying for full multiple expansion; ideal if you expect a clean Q2 beat and no fresh export restrictions.
• Avoid chasing META/MSFT/ORCL at current levels until NVDA proves the next ramp; these names are indirect beneficiaries, but they are also the first to de-rate if the market questions AI capex ROI over the next quarter.